Dividend Aristocrats Part 25 of 52: CR Bard
November 14, 2015 at 09:30 AM EST
What if someone could apply a buy-dispose-repeat process to the medical supply industry? Certainly, that would be a very profitable company. CR Bard (BCR) does just that.In fact, 90% of the company’s products are single use products.